FDA Clarifies ANDA Active Ingredient Sameness Evaluation In Draft Guidance | MoFo Life Sciences

On November 8, 2022, FDA issued a draft guidance document on Sameness Evaluations in an ANDA — Active Ingredients (“Draft Guidance”). In the Draft Guidance, FDA indicated that the...

Related Keywords

,Mofo Life Sciences ,Mofo Life ,Sameness Evaluations ,Active Ingredients ,Draft Guidance ,Sameness Evaluation ,Different Classes ,Small Molecule ,Ingredient Sameness Evaluations ,